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Modeling Parkinson’s Disease in the Budding Yeast, Saccharomyces cerevisiae
Yuri Takenaka, Victoria Haak, and Nicanor Austriaco, O.P. 
Department of Biology, Providence College, Providence, RI 02918
ABSTRACT
Parkinson’s Disease (PD) is the second most common, incurable
neurodegenerative disorder worldwide. PD patients have
accumulations of abnormal proteins called Lewy Bodies (LBs)
within their neurons that trigger cell death. Damaged and dead
neurons lead to decline in dopamine levels, triggering the
symptoms of Parkinson’s such as muscle stiffness, tremors, and
slowed movement. Numerous studies have shown that the human
protein, α-synuclein and tau, are two major components of Lewy
Bodies. To study the relationship between protein aggregation
and cell death, we have created a system to co-overexpress
human alpha-synuclein fused to GFP and human tau fused to
mCherry in the budding yeast, Saccharomyces cerevisiae.
Preliminary data suggests that low levels of α-synuclein-GFP
appear to localize to the yeast cell membrane while tau-mCherry
localizes to the vacuole.
CONCLUSIONS
• Lewy Bodies can successfully be modeled in yeast


































Alpha-synuclein and tau are proteins located in the neurons of
mammalian cells. The α-synuclein protein is believed to play a
key role in monitoring the concentration neurotransmitters as
well as membrane binding. The tau protein is thought to
stabilize microtubules and are found in abundance in neurons.
Two strains of Saccharmocyes cerevisiae (hitox and lotox) that
overexpress α-synuclein were transformed with tau. to create a
system that colocalizes both proteins to model the formation of
Lewy Bodies.
FIGURE 2: The wildtype LOTOX strain was grown in YEPGlu media for 24 hours. Cells were then transferred to
YEPRaf media and then transferred to YEPGal after 4 hours to induce α-synuclein expression. The wildtype W303
strain was transformed with a plasmid expressing human Tau and grown in SD-trp liquid media for 24 hours. Cells
were transferred to SRaf-Trp media and stained with FM464. Cells were transferred to SGal-Trp to induce the tau
protein. Both strains were imaged using a Zeiss LSM 700 laser confocal microscope.
FIGURE 1: Accumulations of Lewy Bodies 
Composed of Tau and α-Synuclein Leads Is Linked 
to Parkinson’s Disease Progression
LOTOX HITOX
FIGURE 5: Both strains were transformed with a plasmid expressing
Tau with a copper promoter. The cells were grown in SD-trp liquid
media for 24 hours, Cells were transferred to Sraff-trp and then SGal-trp
to induce α-synuclein. After 4 hours, a 100 mM copper sulfate was added
to the culture to induce tau. Both strains were imaged after 5 hours of tau
induction.
FIGURE 3: LOTOX and HITOX were transformed with a plasmid expressing Tau. Both strains were grown in SD-trp for
24 hours and transferred to Sraff-trp media. After 3 hours, the cells were transferred to SGal-trp to induce both proteins. The
cells were imaged for 4 hours. The colocalization of proteins decreases as time progresses. The fluorescence of GFP, RDP,
and PMT was quantified. The fluorescence of GFP increases as time progresses.
FIGURE 3: Colocalization of Tau and α-Synuclein Decreases Over Time









FIGURE 1: Aggregation of α-synuclein and tau have been linked to the
formation of Lewy Bodies. The abnormal accumulation of both proteins
triggers cell death, leading to symptoms of Parkinson’s Disease.
FIGURE 4: Tau and α-Synuclein Have Distinct 
Cellular Localizations After 24 Hours
FIGURE 4: The LOTOX and HITOX strains imaged after 24 hours of
induction showed no overlap.
LOTOX HITOX
FIGURE 5: Altering the Relative Expression 



















































• Continue to alter the relative expression of Tau and         
α-Synuclein
• Perform drug therapies on the cells to hopefully alleviate 
aggregation 
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